Effect of Alirocumab on Lipoprotein (a) and Cardiovascular Risk After Acute Coronary Syndrome

Collaboration

Year: 2020

Bittner, VA; Szarek, M; Aylward, PE; Bhatt, D.L.; Diaz, R; Edelberg, JM; Fras, Z; Goodman, S.G.; Halvorsen, S; Hanotin, C; Harrington, RA; Jukema, JW; Loizeau, V; Moriarty, PM; Moryusef, A; Pordy, R; Roe, M.T.; Sinnaeve, P; Tsimikas, S; Vogel, R; White, HD; Zah

Title: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

• D1